Lucid Diagnostics Inc. Royalty Expense
Lucid Diagnostics Inc. (LUCD) reported Royalty Expense of $23.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RoyaltyExpense · last filed 2023-03-14
- Lucid Diagnostics Inc. royalty expense for the quarter ending 2022-03-31 was $10.00K.
- Lucid Diagnostics Inc. royalty expense for fiscal 2022 was $23.00K, a 8.00% decline from fiscal 2021.
- Lucid Diagnostics Inc. royalty expense for fiscal 2021 was $25.00K.
| Period end | Royalty Expense 3 month | Royalty Expense 12 month |
|---|---|---|
| 2022-12-31 | $23.00K 10-K · filed 2023-03-14 | |
| 2022-03-31 | $10.00K 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $25.00K 10-K · filed 2023-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |